Chi­na ap­proves Eli Lil­ly's weight loss drug as coun­try launch­es obe­si­ty aware­ness cam­paign

Eli Lil­ly’s tirzepatide has been ap­proved for weight man­age­ment in Chi­na, en­ter­ing what’s ex­pect­ed to be a sub­stan­tial mar­ket for GLP-1s.

Tirzepatide — mar­ket­ed in the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER